                                                6
         Abstract
         The present invention discloses 3-trichloroacetyl-2, 2-dimethylcyclopropane
   ethyl ester drug synthesis method, comprises the following steps: 3-trichloroacetyl-2,
 5 2-dimethylcyclopropanecarboxylic acid ethyl ester and sodium sulphate solution were
   added to the reaction vessel, controlled the stirring speed, reacted, then added
   4-methyl-cyclohexanol solution, raised the temperature, continued to react; continued
   to react after adding titanium dichloride powder in batches, standing, layered the
   solution and separated oil, extracted it with the alpha methylbenzene solution for
10 multiple times, washed with the 2-methyl-1-butanol solution for several times,
   washed with triethyl sulfide solution for several times, recrystallized in the
   triethylamine solution, dehydrated with dehydration, got the finished product
   3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester.

                                                   1
   3-trichloroacetyl-2,    2-dimethylcyclopropanecarboxylic        acid ethyl ester drug
   synthesis method
         FIELD OF THE INVENTION
 5       The present invention relates to a medicine preparation method which belongs to
   the field of organic synthesis, more particularly, relates to 3-trichloroacetyl-2,
   2-dimethylcyclopropanecarboxylic acid ethyl ester drug synthesis method.
         GENERAL BACKGROUND
10      3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester drug is
   mainly used as drug intermediates, and its synthesis method is of great significance.
   Existing synthesis methods are mostly using chromium trioxide as the reactant, the
   final reaction yield is not ideal, and the three oxidation chromium is polluting to the
   environment, the process of synthesis method is complex. Therefore, it is necessary to
15 propose a new synthesis method.
         SUMMARY
         Based on the technical problems of the background technology, the purpose of the
   present invention is to provide 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic
20 acid ethyl ester drug synthesis method, comprises the following steps:
         A: 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester and 1.6
   L sodium sulphate solution were added to the reaction vessel, controlled the stirring
   speed at 180-210 rpm, reacted for 30-50min, then added 4-methyl-cyclohexanol
   solution, raised the temperature to 40-46 "C, continued to react for 40-60min;
25       B: continued to react for 2-3 hours after adding titanium dichloride powder in
   batches within 60-80min, standing for 30-40min, layered the solution and separated oil,
   extracted it with the alpha methylbenzene solution for multiple times, washed with the
   2-methyl- 1-butanol solution for several times, washed with triethyl sulfide solution for
   several times, recrystallized in the triethylamine solution, dehydrated with dehydration,
30 got the finished product 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid

                                                   2
   ethyl ester.
         Preferably, the sodium sulfate solution has a mass fraction of 15-22%.
         Preferably, the mass fraction of the 4-methyl cyclohexanol solution is 20-26%.
         Preferably, the alpha-methylbenzene solution has a mass fraction of 40-47%.
 5       Preferably, the 2-methyl-1-butanol solution has a mass fraction of 60-65%.
         Preferably, the mass fraction of triethyl sulfide solution is 70-76%.
         Preferably, the mass fraction of triethylamine solution is 80-85%.
         Throughout the reaction process can be the following reaction formula:
                      CH,                                                            CHa
                    /\
          C CCH- C
                           C00C 2Hs +   C7H 14o +   (C5H5)2TiC12             CICc
             NH2   OH
10       Compared with the synthesis method disclosed in the background art, the
   invention provides 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl
   ester drug synthesis method, it is unnecessary to use chromium trioxide, avoiding the
   environmental pollution when used chromium trioxide, reducing intermediate links
   reaction, decreasing the reaction time and improving the reaction yield, at the same
15 time, the present invention provides a new synthetic route which has laid a good
   foundation for further enhancing the yield of the reaction.
         DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
         The following examples with reference to specific embodiments of the present
20 invention are further illustrated:
         Embodiment 1
         3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester synthesis
   method, comprises the following steps:
         A: 3 mol 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester
25 drug and 1.6 L sodium sulphate solution with a mass fraction of 15% was added to the
   reaction vessel, controlled the stirring speed at 180 rpm, reacted for 30min, then added
   3 mol 4-methyl-cyclohexanol solution with a mass fraction of 20%, raised the

                                                  3
   temperature to 40'C, continued to react for 40min;
         B: continued to react for 2 hours after adding 2mol titanium dichloride powder in
   batches within 60min, standing for 30min, layered the solution and separated oil
   extracted it five times with the alpha methylbenzene solution with a mass fraction of
 5 40%, washed six times with the 2-methyl-1-butanol solution with a mass fraction of
   60%, washed three times with triethyl sulfide solution with a mass fraction of 70%,
   recrystallized in the triethylamine solution with a mass fraction of 80%, dehydrated
   with    anhydrous     sodium    sulfate   dehydration,   got    the   finished  product
   3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester 766.29g, yield
10 of89%.
         Embodiment 2
         3-trichloroacetyl-2,  2-dimethylcyclopropanecarboxylic     acid ethyl ester drug
   synthesis method, comprises the following steps:
15       A: 3 mol 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester
   drug and 1.6 L sodium sulphate solution with a mass fraction of 18% was added to the
   reaction vessel, controlled the stirring speed at 190 rpm, reacted for 40min, then
   added 3.5 mol 4-methyl-cyclohexanol solution with a mass fraction of 23%, raised the
   temperature to 43 C, continued to react for 50min;
20       B: continued to react for 2.5 hours after adding 2.5 mol titanium dichloride
   powder in four times within 70min, let standing for 35min, layered the solution and
   separated oil, extracted it five times with the alpha methylbenzene solution with a
   mass fraction of 43%, washed six times with the 2 - methyl-1-butanol solution with a
   mass fraction of 62%, washed three times with triethyl sulfide solution with a mass
25 fraction of 73%, recrystallized in the triethylamine solution with a mass fraction of
   82%, dehydrated with anhydrous calcium sulphate dehydration, got the finished
   product 3-trichloroacetyl-2,     2-dimethylcyclopropanecarboxylic     acid ethyl   ester
   792.12g,yield of 92%.
30

                                                   4
         Embodiment 3
         3-trichloroacetyl-2,  2-Dimethylcyclopropanecarboxylic     acid ethyl ester drug
   synthesis method, comprises the following steps:
         A: 3 mol 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester
 5 drug and 1.6 L sodium sulphate solution with a mass fraction of 22% was added to the
   reaction vessel, controlled the stirring speed at 210 rpm, reacted for 50min, then
   added 4 mol 4-methyl-cyclohexanol solution with a mass fraction of 26%, raised the
   temperature to 46 0C,    continued to react for 60min;
         B: continued to react for 3 hours after adding 3 mol titanium dichloride powder
10 in five times within 80min, let standing for 40min, layered the solution and separated
   reservoir, extracted it six times using the alpha methylbenzene solution with a mass
   fraction of 47%, washed seven times with the 2-methyl-1-butanol solution with a
   mass fraction of 65%, washed five times with triethyl sulfide solution with a mass
   fraction of 76%, recrystallized in the triethylamine solution with a mass fraction of
15 85%, dehydrated with phosphorus pentoxide dehydration, got the finished product
   3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester 826.56g, yield
   of 96%.
         The embodiments of the present invention are merely preferred embodiments of
   the present invention, but the range of the present invention is not limited this, and
20 any person who is familiar with those skilled in the arts, within the technical range of
   the present invention. It is intended that the technical solution and its inventive
   concept be replaced or modified equivalently with reference to the range of the
   invention.

                                                   5
         Claims
          1. 3-trichloroacetyl-2, 2-dimethylcyclopropane ethyl ester drug synthesis method,
   comprises the following steps:
 5       A: 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester and
   1.6 L sodium sulphate solution were added to the reaction vessel, controlled the
   stirring     speed    at    180-210   rpm,    reacted     for  30-50min,     then    added
   4-methyl-cyclohexanol solution, raised the temperature to 40-46 'C, continued to
   react for 40-60min;
10       B: continued to react for 2-3 hours after adding titanium dichloride powder in
   batches within 60-80min, standing for 30-40min, layered the solution and separated
   oil, extracted it with the alpha methylbenzene solution for multiple times, washed
   with the 2 - methyl-1-butanol solution for several times, washed with triethyl sulfide
   solution for several times, recrystallized in the triethylamine solution, dehydrated with
15 dehydration,          got       the      finished        product       3-trichloroacetyl-2,
   2-dimethylcyclopropanecarboxylic acid ethyl ester.
         2. 3-trichloroacetyl-2, 2-dimethylcyclopropane ethyl ester drug synthesis method
   according to claim 1 wherein the sodium sulfate solution has a mass fraction of
20 15-22%.
         3. 3-trichloroacetyl-2, 2-dimethylcyclopropane ethyl ester drug synthesis method
   according to claim 1 wherein the mass fraction of the 4-methyl cyclohexanol solution
   is 20-26%.
25
         4. 3-trichloroacetyl-2, 2-dimethylcyclopropane ethyl ester drug synthesis method
   according to claim 1 wherein the alpha-methylbenzene solution has a mass fraction of
   40-47%.

